How Did COVID Push Immunology Forward?
July 24, 2026Core Framework & Diagram How Did Single-Cell Technology Transform Immune Research?
July 24, 2026
How Did Single-Cell Technology Transform Immune Research?
Before, we were looking at a forest. Now we can see each tree clearly
By the Editors 1-min read
Traditional immunology research was like putting a mixed fruit juice into an instrument for analysis — you could know it had orange, apple, and banana, but you couldn't know each orange's condition, or whether one particular apple had a problem.
Single-cell RNA sequencing (scRNA-seq) technology, which appeared around 2009, for the first time allowed scientists to build 'complete gene expression portraits' for each individual cell — simultaneously analyzing tens of thousands of cells, each cell's state clearly visible.
This technology triggered a genuine revolution in immunology: large numbers of previously unknown cell subtypes were discovered, many 'known' cells' functions were reunderstood, and disease mechanism comprehension was fundamentally reshaped.
KEY TAKEAWAYS
01
Single-cell RNA sequencing (scRNA-seq) shifted immunology from 'population average' to 'single-cell resolution' perspective, revealing the immune system's heterogeneity far exceeds previous understanding.
02
CITE-seq, spatial transcriptomics, and single-cell TCR/BCR sequencing combined let researchers simultaneously describe each cell's gene expression, protein markers, position, and antigen recognition capacity.
03
In tumor immunology, single-cell technology discovered 'progenitor exhausted T cells' and other key subpopulations, directly guiding PD-1 treatment response prediction biomarker research.
04
The Human Cell Atlas (HCA) project is using single-cell technology to map complete reference profiles of all human cell types, becoming the foundational reference framework for future disease research.
05
Single-cell technology's main limitations: time-point snapshots can't capture dynamic processes; tissue position information is lost (spatial transcriptomics partially compensates); high analysis costs. Next-generation multi-omics and spatial multi-omics technologies are progressively breaking through these limitations.
Art 164
Major Controversies in Immunology History
→
Art 165
Major Misconceptions in Immunology History
→